Literature DB >> 15910223

Molecular analysis of isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates recovered from Barcelona.

Pere Coll1, Lina Marcela Aragón, Fernando Alcaide, Mateo Espasa, Montserrat Garrigó, Julià González, Jose M Manterola, Pilar Orús, Margarita Salvadó.   

Abstract

We studied the presence of mutations in the whole katG gene and specific regions of the oxyR-ahpC and mabA-inhA regulatory region in 61 Mycobacterium tuberculosis isoniazid-resistant isolates. An 81-bp region of the rpoB gene was also sequenced in 17 rifampin-resistant strains. Alterations in the katG gene were detected in 55% of the isolates. Mutation in codon 315 was the most prevalent (32%). Strains showed a high level of resistance, and most maintained a substantial catalase-peroxidase activity. Three strains with an isoniazid MIC of >or=32 microg/ml lacked catalase-peroxidase activity. Two of them had deletions in the catalytic domain of the KatG protein. One strain with deletion and three strains with mutations in the C-terminal domain showed low-level resistance and conserved the catalase-peroxidase activity. Mutations in the mabA-inhA regulatory region were identified in 32% of the isolates. All had low-level resistance, and the vast majority conserved catalase-peroxidase activity. Seventeen percent of the isoniazid-resistant isolates had no detectable alterations at the studied loci. Resistance to rifampin was associated with mutations in the 81-bp of the rpoB gene in all cases. IS6110 analysis indicated that recent transmission contributed substantially to the emergence of isoniazid- resistant tuberculosis in Barcelona through short transmission chains. A rapid genotypic assay, including the 315-katG codon and the -15 nucleotide of the mabA-inhA regulatory region, may cover 62% of isoniazid- resistant strains in Barcelona. In contrast, the targeting of the 81-bp region of rpoB would detect all our rifampin-resistant isolates.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15910223     DOI: 10.1089/mdr.2005.11.107

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  10 in total

1.  Evaluation of GenoFlow DR-MTB Array Test for Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis.

Authors:  B Molina-Moya; G Kazdaglis; A Lacoma; C Prat; A Gómez; R Villar-Hernández; E García-García; L Haba; J Maldonado; S Samper; J Ruiz-Manzano; J Domínguez
Journal:  J Clin Microbiol       Date:  2016-02-10       Impact factor: 5.948

2.  Pyrosequencing for rapid molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis strains and clinical specimens.

Authors:  N García-Sierra; A Lacoma; C Prat; L Haba; J Maldonado; J Ruiz-Manzano; P Gavin; S Samper; V Ausina; J Domínguez
Journal:  J Clin Microbiol       Date:  2011-08-03       Impact factor: 5.948

3.  Biological and molecular characteristics of Mycobacterium tuberculosis clinical isolates with low-level resistance to isoniazid in Japan.

Authors:  Chiyoji Abe; Ikuo Kobayashi; Satoshi Mitarai; Masako Wada; Yoshiko Kawabe; Tetsuya Takashima; Katsuhiro Suzuki; Li-Hwei Sng; Suxing Wang; Hla Hla Htay; Hideo Ogata
Journal:  J Clin Microbiol       Date:  2008-05-28       Impact factor: 5.948

4.  Frequency and Distribution of Tuberculosis Resistance-Associated Mutations between Mumbai, Moldova, and Eastern Cape.

Authors:  S B Georghiou; M Seifert; D Catanzaro; R S Garfein; F Valafar; V Crudu; C Rodrigues; T C Victor; A Catanzaro; T C Rodwell
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

5.  Rapid detection of MDR-Mycobacterium tuberculosis using modified PCR-SSCP from clinical Specimens.

Authors:  Imani Fooladi Abbas Ali; Farzam Babak; Mousavi Seyed Fazlollah; Jonaidi Jafari Nematollah
Journal:  Asian Pac J Trop Biomed       Date:  2014-05

6.  GenoType MTBDRplus assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis strains and clinical samples.

Authors:  A Lacoma; N Garcia-Sierra; C Prat; J Ruiz-Manzano; L Haba; S Rosés; J Maldonado; J Domínguez
Journal:  J Clin Microbiol       Date:  2008-09-10       Impact factor: 5.948

7.  In vitro activity of novel rifamycins against rifamycin-resistant Staphylococcus aureus.

Authors:  Christopher K Murphy; Steve Mullin; Marcia S Osburne; John van Duzer; Jim Siedlecki; Xiang Yu; Kathy Kerstein; Michael Cynamon; David M Rothstein
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

8.  Multicenter laboratory evaluation of the MB/BacT Mycobacterium detection system and the BACTEC MGIT 960 system in comparison with the BACTEC 460TB system for susceptibility testing of Mycobacterium tuberculosis.

Authors:  Montserrat Garrigó; Lina Marcela Aragón; Fernando Alcaide; Sonia Borrell; Eugenia Cardeñosa; Juan José Galán; Julián Gonzalez-Martín; Nuria Martin-Casabona; Carmen Moreno; Margarita Salvado; Pere Coll
Journal:  J Clin Microbiol       Date:  2007-04-18       Impact factor: 5.948

9.  PCR-restriction fragment length polymorphism for rapid, low-cost identification of isoniazid-resistant Mycobacterium tuberculosis.

Authors:  Maxine Caws; Dau Quang Tho; Phan Minh Duy; Nguyen Thi Ngoc Lan; Dai Viet Hoa; Mili Estee Torok; Tran Thi Hong Chau; Nguyen Van Vinh Chau; Nguyen Tran Chinh; Jeremy Farrar
Journal:  J Clin Microbiol       Date:  2007-04-11       Impact factor: 5.948

10.  Resistant mutants of Mycobacterium tuberculosis selected in vitro do not reflect the in vivo mechanism of isoniazid resistance.

Authors:  Indra L Bergval; Anja R J Schuitema; Paul R Klatser; Richard M Anthony
Journal:  J Antimicrob Chemother       Date:  2009-07-04       Impact factor: 5.790

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.